Literature DB >> 31238008

Two distinct E3 ligases, SCFFBXL19 and HECW1, degrade thyroid transcription factor 1 in normal thyroid epithelial and follicular thyroid carcinoma cells, respectively.

Jia Liu1,2, Su Dong2,3, Heather Wang2, Lian Li2, Qinmao Ye2, Yanhui Li2,3, Jiaxing Miao2, Sissy Jhiang2, Jing Zhao2, Yutong Zhao2.   

Abstract

Thyroid transcription factor 1 (TTF1) regulates the tissue-specific expression of genes. However, the molecular regulation of TTF1 in thyroid normal and carcinoma cells has not been revealed. Here we identify 2 distinct ubiquitin E3 ligases that are responsible for TTF1 degradation in normal thyroid cells and carcinoma cells, respectively. Phorbol myristate acetate induced TTF1 protein degradation in the ubiquitin-proteasome system in both HTori3 thyroid follicular epithelial cells and follicular thyroid carcinoma 133 (FTC133) cells. Lysine 151 residue was identified as a ubiquitin acceptor site within TTF1 in both cell types. Overexpression of E3 ubiquitin protein ligase 1 containing HECT, C2, and WW domain (HECW1) induced TTF1 degradation and ubiquitination in Htori3 cells but not in FTC133 cells. Overexpression of ubiquitin E3 ligase subunit FBXL19 increased TTF1 ubiquitination and degradation in FTC133 cells, but it had no effect on TTF1 levels in Htori3 cells. Overexpression of TTF1 increased thyroglobulin and sodium/iodide symporter mRNA levels, cell migration, and proliferation in HTori3 cells, whereas the effects were reversed by the overexpression of HECW1. This study reveals an undiscovered molecular mechanism by which TTF1 ubiquitination and degradation is regulated by different E3 ligases in thyroid normal and tumor cells.-Liu, J., Dong, S., Wang, H., Li, L., Ye, Q., Li, Y., Miao, J., Jhiang, S., Zhao, J., Zhao, Y. Two distinct E3 ligases, SCFFBXL19 and HECW1, degrade thyroid transcription factor 1 in normal thyroid epithelial and follicular thyroid carcinoma cells, respectively.

Entities:  

Keywords:  FBXL19; HECW1; TTF1; different cell types; ubiquitination

Mesh:

Substances:

Year:  2019        PMID: 31238008      PMCID: PMC6704452          DOI: 10.1096/fj.201900415R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  50 in total

Review 1.  Ubiquitin: same molecule, different degradation pathways.

Authors:  Michael J Clague; Sylvie Urbé
Journal:  Cell       Date:  2010-11-24       Impact factor: 41.582

2.  Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B.

Authors:  O Kaufmann; M Dietel
Journal:  Histopathology       Date:  2000-01       Impact factor: 5.087

3.  Transcriptional activation of the thyroglobulin promoter directing suicide gene expression by thyroid transcription factor-1 in thyroid cancer cells.

Authors:  H Shimura; H Suzuki; A Miyazaki; F Furuya; K Ohta; K Haraguchi; T Endo; T Onaya
Journal:  Cancer Res       Date:  2001-05-01       Impact factor: 12.701

Review 4.  The Nedd4-like family of E3 ubiquitin ligases and cancer.

Authors:  Ceshi Chen; Lydia E Matesic
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

5.  Loss of Shp2 in alveoli epithelia induces deregulated surfactant homeostasis, resulting in spontaneous pulmonary fibrosis.

Authors:  Xue Zhang; Yun Zhang; Bo Tao; Li Teng; Yanwei Li; Rui Cao; Qiu Gui; Madong Ye; Xiaozhou Mou; Hongqiang Cheng; Hu Hu; Ren Zhou; Ximei Wu; Qiangmin Xie; Wen Ning; Maode Lai; Huahao Shen; Gen-Sheng Feng; Yuehai Ke
Journal:  FASEB J       Date:  2012-02-23       Impact factor: 5.191

6.  Expression of thyroid transcription factor-1 (TTF-1) in human C cells and medullary thyroid carcinomas.

Authors:  R Katoh; E Miyagi; N Nakamura; X Li; K Suzuki; K Kakudo; M Kobayashi; A Kawaoi
Journal:  Hum Pathol       Date:  2000-03       Impact factor: 3.466

7.  Hyperoxia treatment of TREK-1/TREK-2/TRAAK-deficient mice is associated with a reduction in surfactant proteins.

Authors:  Andreas Schwingshackl; Benjamin Lopez; Bin Teng; Charlean Luellen; Florian Lesage; John Belperio; Riccardo Olcese; Christopher M Waters
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-24       Impact factor: 5.464

8.  Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-β.

Authors:  Sarah L Kenny; Hilary A McBride; Jackie Jamison; W Glenn McCluggage
Journal:  Am J Surg Pathol       Date:  2012-06       Impact factor: 6.394

9.  RNF43 interacts with NEDL1 and regulates p53-mediated transcription.

Authors:  Keisuke Shinada; Tadasuke Tsukiyama; Takuya Sho; Fumihiko Okumura; Masahiro Asaka; Shigetsugu Hatakeyama
Journal:  Biochem Biophys Res Commun       Date:  2010-11-23       Impact factor: 3.575

10.  Thyroid follicle formation and thyroglobulin expression in multipotent endodermal stem cells.

Authors:  Risheng Ma; Rauf Latif; Terry F Davies
Journal:  Thyroid       Date:  2013-03-18       Impact factor: 6.568

View more
  5 in total

1.  ETS1-activated SNHG10 exerts oncogenic functions in glioma via targeting miR-532-3p/FBXL19 axis.

Authors:  Lide Jin; Shengquan Huang; Congjin Guan; Shun Chang
Journal:  Cancer Cell Int       Date:  2020-12-09       Impact factor: 5.722

2.  MARCH6 promotes Papillary Thyroid Cancer development by destabilizing DHX9.

Authors:  Yang Liu; Siyuan Xu; Ying Huang; Shaoyan Liu; Zhengang Xu; Minghui Wei; Jie Liu
Journal:  Int J Biol Sci       Date:  2021-08-03       Impact factor: 6.580

Review 3.  Posttranslational Modifications in Thyroid Cancer: Implications for Pathogenesis, Diagnosis, Classification, and Treatment.

Authors:  Jordan M Broekhuis; Benjamin C James; Richard D Cummings; Per-Olof Hasselgren
Journal:  Cancers (Basel)       Date:  2022-03-22       Impact factor: 6.639

4.  SCF FBXW17 E3 ubiquitin ligase regulates FBXL19 stability and cell migration.

Authors:  Su Dong; Jianxin Wei; Rachel K Bowser; Bill B Chen; Rama K Mallampalli; Jiaxing Miao; Qinmao Ye; Kevin C Tran; Yutong Zhao; Jing Zhao
Journal:  J Cell Biochem       Date:  2020-10-14       Impact factor: 4.429

5.  Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma.

Authors:  Chao Wang; Keqin Dong; Yuning Wang; Guang Peng; Xu Song; Yongwei Yu; Pei Shen; Xingang Cui
Journal:  BMC Cancer       Date:  2021-08-04       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.